Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27263918 | 0.98 | CA12 (0.43) | CA12CA7CA14SMN1; SMN2MAPT | |
| Water SCHEMBL27737003 | 0.96 | CA12 (0.42) | CA12CA7CA14SMN1; SMN2MAPT | |
| SCHEMBL465059 | 0.89 | SMN1; SMN2 (0.46) | CA12CA7CA14SMN1; SMN2MAPT | |
| SCHEMBL17443158 | 0.86 | CA1 (0.46) | CA12CA7CA14SMN1; SMN2TSHR | |
| SCHEMBL465093 | 0.84 | CA12 (0.48) | CA12CA7CA14SMN1; SMN2TSHR | |
| Water SCHEMBL27714980 | 0.82 | CA12 (0.46) | CA12CA7CA14SMN1; SMN2TSHR | |
| SCHEMBL27896468 | 0.82 | CA12 (0.46) | CA12CA7CA14SMN1; SMN2TSHR | |
| SCHEMBL8991325 | 0.77 | KDM4E (0.39) | MAPTCA1CA2ALDH1A1KDM4E | |
| SCHEMBL27461728 | 0.75 | CA1 (0.32) | CA1CA2 | |
| SCHEMBL27416946 | 0.74 | CA1 (0.36) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 670 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4401797-A1 | PHARMACEUTICAL COMPOSITIONS FOR IMAGING, DIAGNOSIS AND TREATMENT OF CANCER | Jubilant Draximage, Inc. (CA) | 2024-07-24 | — | — | EP | claimed |
| CN-118021741-A | Preparation method of ellagic acid crystal particles and application of ellagic acid crystal particles in anti-Alzheimer disease drugs | 中国科学院兰州化学物理研究所 | 2024-05-14 | — | — | CN | claimed |
| CN-117925735-A | Application of azo reductase in catalyzing reduction of p-benzoquinone to generate hydroquinone | 中国科学院武汉病毒研究所 | 2024-04-26 | — | — | CN | claimed |
| CN-110740725-B | Composition containing benzoic acid amide compound and cyclodextrin solubilizer | 株式会社爱茉莉太平洋 | 2024-01-12 | — | — | CN | claimed |
| CN-116121336-B | Blood fat three-item test strip and preparation method thereof | 复星诊断科技(长沙)有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-116121336-A | Blood fat three-item test strip and preparation method thereof | 复星诊断科技(长沙)有限公司 | 2023-05-16 | — | — | CN | claimed |
| US-20230084536-A1 | PHARMACEUTICAL COMPOSITIONS FOR IMAGING, DIAGNOSIS AND TREATMENT OF CANCER | Jubilant Radiopharma (CA) | 2023-03-16 | — | — | US | claimed |
| WO-2023037337-A1 | PHARMACEUTICAL COMPOSITIONS FOR IMAGING, DIAGNOSIS AND TREATMENT OF CANCER | Jubilant Radiopharma (CA) | 2023-03-16 | — | — | WO | claimed |
| CN-107084954-B | A kind of preparation method of fluorescent optical sensor, a kind of method for detecting tyrosinase | 安徽师范大学 | 2019-09-27 | — | — | CN | claimed |
| CN-106282323-B | High-sensitivity DNA fluorescence analysis method for generating copper nanoparticles based on polythymine as template | 南京理工大学 | 2019-08-09 | — | — | CN | claimed |
| US-5750657-A | Methods and compositions using fibrin monomer to make a fibrin sealant | BRISTOL-MYERS SQUIBB COMPANY (US) | 1998-05-12 | — | — | US | claimed |
| WO-1997013146-A1 | BLOOD CONTROL STANDARD | HYCOR BIOMEDICAL, INC. (US) | 1997-04-10 | — | — | WO | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5534374-A | Migration imaging members | XEROX CORPORATION (US) | 1996-07-09 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0673784-A2 | Recording sheets containing oxazole, isooxazole, oxazolidinone, oxazoline salts, morpholine, thiazole, thiazolidine, thiadiazole, and phenothiazine compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| CN-1091315-A | Fibrin sealant compositions and using method thereof | SQUIBB & SONS INC (US) | 1994-08-31 | — | — | CN | claimed |
| EP-0592242-A1 | Fibrin sealant compositions and method for utilizing same | E.R. SQUIBB & SONS, INC. (US) | 1994-04-13 | — | — | EP | claimed |